ALEXANDRIA
Dead / Cancelled — Cancelled — Section 8 (as of 03 Oct 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87646697
- Registration number
- 5700446
- Mark type
- Stylized text
- Filed
- 16 Oct 2017
- Published for opposition
- 01 Jan 2019
- Registered
- 19 Mar 2019
- Attorney of record
- Joel D. Leviton
Goods and services
- Class 001 — Chemicals: Antibody reagents for scientific purposes; nucleic acids for scientific purposes; clinical diagnostic reagents and clinical diagnostic reagent kits comprised primarily of monoclonal antibodies and monoclonal antibody fragments, buffers and reagents to detect the presence of antibody target antigens in human or animal tissues, or to detect the presence of therapeutic proteins or replacement enzymes in human or animal tissues for scientific laboratory use; chemical preparations for use in DNA analysis other than for medical or veterinary purposes; proteins for use in discovery, optimization and preclinical development of therapeutic and diagnostic antibodies using recombinant DNA technology other than for medical use; enzymes for use in the continuous homogenous isothermal amplifications of specific DNA templates other than for medical use; proteins for detecting antibodies other than for medical use; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research
- Class 005 — Pharmaceuticals: Diagnostic and therapeutic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of infectious, inflammatory and autoimmune disorders, cancer, metabolic and endocrine, cardiovascular disorders and hemostatic disorders; biochemical and biological substances for medical diagnostics and analysis, namely, diagnostic agents and reagents; pharmaceutical preparations and substances for the treatment of infectious, inflammatory and autoimmune disorders, cancer, metabolic and endocrine, cardiovascular disorders and hemostatic disorders; chemical preparations in the nature of reagents for use in DNA medical diagnostic analysis; nucleic acid sequences for medical use; synthetic peptides for pharmaceutical purposes for the treatment of infectious, inflammatory and autoimmune disorders, cancer, metabolic and endocrine, cardiovascular disorders and hemostatic disorders
Owner
- Isogenica Ltd, Saffron Walden, Essex, GB
- Isogenica Ltd, Saffron Walden, Essex, GB
- Isogenica Ltd, Saffron Walden, Essex, GB
Prosecution history
- 03 Oct 2025 — CANCELLED SEC. 8 (6-YR)
- 19 Mar 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Mar 2019 — REGISTERED-PRINCIPAL REGISTER
- 01 Jan 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jan 2019 — PUBLISHED FOR OPPOSITION
- 12 Dec 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Nov 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Nov 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Nov 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Nov 2018 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 04 Jun 2018 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Jun 2018 — FINAL REFUSAL E-MAILED
- 04 Jun 2018 — FINAL REFUSAL WRITTEN
- 23 May 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 May 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE